HOME   |    PDF   |   


Title

Bisphosphonate and medication induced necrosis of jaws

 

Author

Altaf H Malik

 

Affiliation

Department of oral and Maxillofacial Surgery Government Dental College Srinagar-190010, Jammu and Kashmir, India; *Corresponding author

 

Email

Altaf H Malik - E - mail: drmalikaltaf@gmail.com; Phone: +91 919469000615

 

Article Type

Research Article

 

Date

Received January 1, 2025; Revised January 31, 2025; Accepted January 31, 2025, Published January 31, 2025

 

Abstract

The bisphosphonates are prescribed drugs to prevent bone resorption particularly in patients having certain malignancies. However, there is a potential risk of osteonecrosis of jaws in patients receiving dental treatment. Therefore, it is of interest to evaluate the chances of osteonecrosis in patients referred for management of osteonecrosis in whom dental treatment was carried out by the referring dental professionals. Hence, 86 patients were studied, where 18 patients had developed osteonecrosis particularly after dental extraction of which 13 patients were having underlying malignancy. Medication induced necrosis of jaws is more in patients with underlying malignancy or other co-morbidities compared to the patients who aren't suffering from who are not malignancy and dental treatment. Moreover, extraction is a trigger in such patients for developing the debilitating condition.

 

Keywords

Bisphosphonates, osteonecrosis, medication-related osteonecrosis of the jaw

 

Citation

Malik, Bioinformation 21(1): 78-80 (2025)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.